A yeast exosome platform for the next generation of anti-aging skincare.
Nanomère develops vesicles produced by the probiotic yeast Saccharomyces boulardii. We isolate them, load cosmetic actives into them, and prepare them as ingredients for formulators and brands.The approach combines fermentation-based production, a platform that adapts to more than one active, and a business-to-business ingredient model.Request the investor package
- Stage
- Pre-commercial
- Model
- B2B ingredients
- Origin
- Concordia University spinout
- Head office
- Montréal, Québec
One production process. Several possible ingredients.
Some cosmetic actives are difficult to stabilise, to formulate, or to deliver effectively. Nanomère is developing a vesicle platform able to carry different classes of active on one technological base.
Each new active becomes a development programme running the same process: grow, isolate, load, characterise and test.
The process works at laboratory scale.
The founders are carrying out the scientific development in a laboratory at Concordia University.
- Production and isolation of S. boulardii vesicles
- Loading demonstrated with several classes of active
- Characterisation methods established
- Testing in human cells under way
- Declaration of Invention in preparation
We develop ingredients for the people who develop the products.
Our entry market is premium anti-aging skincare. We address formulators, development laboratories and brands.
Ingredient supply
Co-development
Licensing
A platform built to create a portfolio, not a single product.
Fermentation-based production
Several active programmes
Non-human origin
IP and know-how
From proof of concept to industrial evaluation.
- 01Validate the biological activity of the first ingredients
- 02Establish batch-to-batch reproducibility
- 03Optimise purification and loading
- 04Run stability studies in formulation
- 05Produce the first partner batches
- 06Start the first pilot programmes
Two scientific founders who lead the development themselves.
- Christopher Brett, PhD
- Membrane biology and development of the vesicle platform.
- Younes Medkour, PhD
- Aging biology and biological validation of the ingredients.
The technology, the data and the development plan.
The investor package, the roadmap and the material a diligence process needs are shared under a mutual non-disclosure agreement. Your request is handled directly by a founder.
- Investors
- investors@nanomere.ca
- Stage
- Pre-commercial
- Model
- B2B ingredients
- Head office
- Montréal, Québec